Skip to content
Delayed ~15 min

AMGN Amgen

Permanent stock page ↗

Health Care · S&P 500 · Nasdaq 100 · Dow Jones

Next earnings: Tue 2 Feb 2027 · estimated

What 40 analyst firms say about Amgen: their latest ratings, price targets and how far the stock is from them. How it works

460.42 USD+0.14 (+0.03%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

−12.6%to the avg target 402.19 USD−58.23 USD
Buy 15 · Hold 21 · Sell 3

39 rated views · 40 analyst/firm records · 40 firms

Latest report4 Nov 2026avg report date 26 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
  • S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Other indices (2)
  • Nasdaq 100 · Top Picks · 6MNot scored · Average target is not above the current price
  • Nasdaq 100 · Safest consensus · 6MNot scored · Average target is not above the current price
  • Dow Jones · Top Picks · 6MNot scored · Average target is not above the current price
  • Dow Jones · Safest consensus · 6MNot scored · Average target is not above the current price

Recent analyst activity · last 90 days

Our tracked history has 51 reports on AMGN from 28 analyst firms in the last 90 days (40 firms in the past year).

Comparing each firm's latest target with its previous one: 19 raised their price target, 1 lowered it, 2 left it unchanged and 3 have their first observed target in the past year.

Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.

Latest observed target change: Guggenheim raised its target from $378.00 (set 13 Oct 2026) to $435.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJasper HellwegBuy19 Aug 2026460.00 USD
BairdBrian P SkorneySell1 Jun 2026230.00 USD
Bank of America SecuritiesUnnamed analystSell5 Aug 2026317.00 USD
BarclaysEmily FieldHold21 Oct 2026400.00 USD
BernsteinCourtney BreenHold6 Aug 2026345.00 USD
BMO Capital MarketsEvan David SeigermanHold12 Oct 2026415.00 USD
Canaccord GenuityGary NachmanHold5 Aug 2026384.00 USD
Cantor FitzgeraldCarter GouldHold5 Oct 2026440.00 USD
CitigroupGeoff MeachamHold7 Aug 2026405.00 USD
DaiwaNarumi NakagiriBuy13 Aug 2026430.00 USD
DBSNico ChenBuy22 Jan 2026400.00 USD
Deutsche BankUnnamed analystHold5 Feb 2026295.00 USD
DZ BankElmar KrausBuy6 Aug 2026448.00 USD
Erste GroupHans EngelHold18 Sep 2026—
Erste Group BankUnnamed analystHold5 May 2026—
Evercore ISIUmer RaffatBuy1 Jul 2026—
Freedom CapitalUnnamed analystBuy7 May 2026—
Freedom Capital MarketsIlya ZubkovBuy10 Aug 2026450.00 USD
Goldman SachsSalveen RichterBuy13 Oct 2026481.00 USD
GuggenheimVamil DivanHold13 Oct 2026378.00 USD
HSBCMorten HerholdtHold10 Sep 2026425.00 USD
JefferiesAkash TewariHold23 Sep 2026410.00 USD
JPMorganUnnamed analystHold4 Nov 2026425.00 USD
Leerink PartnersDavid RisingerHold5 Aug 2026395.00 USD
MizuhoSalim SyedHold18 Aug 2026352.00 USD
Morgan StanleyTerence FlynnHold7 Oct 2026359.00 USD
OppenheimerJay OlsonBuy23 Oct 2026480.00 USD
Piper SandlerDavid AmsellemBuy20 Aug 2026457.00 USD
Raymond JamesChristopher RaymondHold26 Oct 2026—
RBC Capital MarketsLuca IssiBuy8 Oct 2026430.00 USD
RedburnSteven K ChesneySell6 Jul 2026225.00 USD
ScotiabankLouise ChenBuy28 Sep 2026500.00 USD
TD CowenYaron WerberBuy26 Oct 2026452.00 USD
TruistGregory RenzaHold7 Oct 2026380.00 USD
UBSMichael YeeBuy9 Oct 2026470.00 USD
Weiss RatingsUnnamed analyst—8 Oct 2026—
Wells FargoMohit BansalHold12 Oct 2026430.00 USD
William BlairMatt PhippsBuy5 Aug 2026—
Wolfe ResearchAlexandria HammondHold27 Feb 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 02:19 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.